Zobrazeno 1 - 10
of 51
pro vyhledávání: '"Matthew D. Morgan"'
Autor:
Dimitrios Chanouzas, Michael Sagmeister, Lovesh Dyall, Phoebe Sharp, Lucy Powley, Serena Johal, Jessica Bowen, Peter Nightingale, Charles J. Ferro, Matthew D. Morgan, Paul Moss, Lorraine Harper
Publikováno v:
Arthritis Research & Therapy, Vol 20, Iss 1, Pp 1-10 (2018)
Abstract Background Cardiovascular disease is a leading cause of death in ANCA-associated vasculitis (AAV). An expansion of CD4+CD28null T cells is seen mainly in cytomegalovirus (CMV)-seropositive individuals and has been linked to increased cardiov
Externí odkaz:
https://doaj.org/article/b41be7dea3974d7ca0ac692fada56293
Autor:
Nadezhda A Wall, C Coral Dominguez-Medina, Sian E Faustini, Charlotte N Cook, Andrew McClean, Mark D Jesky, Marisol Perez-Toledo, Matthew D Morgan, Alexandra G Richter, Charles J Ferro, Paul Cockwell, Paul A Moss, Ian R Henderson, Lorraine Harper, Adam F Cunningham
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0195730 (2018)
Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To exa
Externí odkaz:
https://doaj.org/article/b478c3608469450ab171c537a903e74b
Autor:
Sukhwant Sehmi, Ian Litchfield, Sheila Greenfield, Catherine A Hewitt, Charlotte L. Edwardson, Linda Coughlan, Natalie Ives, Sue Jowett, Sarah Tearne, Nathan P Dawkins, Fiona Cramp, Kate Fletcher, Amanda Daley, Matthew D. Morgan, Shalela Kodabuckus, Lorraine Harper, Dimitrios Chanouzas, Caroline Dean, Hollie K Caulfield
Publikováno v:
Rheumatology (Oxford)
Objective Patients with ANCA-associated vasculitis (AAV) experience high levels of fatigue, despite disease remission. This study assessed the feasibility and acceptability of a definitive randomized controlled trial of a behavioural-based physical a
Autor:
J Caplan, S Logan, Rebecca Heath, Matthew D. Morgan, Alan D. Salama, Anna Iacovou, Marilina Antonelou, A Abro, Lorraine Harper, Caroline Ashley
Publikováno v:
Scandinavian journal of rheumatology. 51(2)
The use of rituximab (MabThera®), an anti-CD20 monoclonal antibody, is the most significant development in the management of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis (AAV) since the introduction of cytotoxic therapy in 1950. T
Autor:
Rachel B Jones, David R W Jayne, Matthew D. Morgan, Lorraine Harper, Dimitrios Chanouzas, Lucy O’Malley, Neil Basu, Katie L Druce
Publikováno v:
The Journal of Rheumatology. 47:572-579
Objective.Fatigue is common and burdensome in antineutrophil cytoplasmic antibody–associated vasculitis (AAV). This study aimed to understand how fatigue changes over time following treatment initiation and to determine whether individuals with the
Publikováno v:
Rheumatology. 58
Autor:
William F. Pendergraft, Elizabeth Krarup, Wladimir Szpirt, Lorraine Harper, Juliana Draibe, Jessica Anne Dale, Susan L. Hogan, Matthew D. Morgan, Alan D. Salama, Julie Anne G. McGregor, Keegan Lee, Martin Egfjord, Neil Basu, Paula Dospinescu, Dimitrios Chanouzas, Caroline J. Poulton, Peter Nightingale
Publikováno v:
BMC Nephrology
Chanouzas, D, McGregor, J A G, Nightingale, P, Salama, A D, Szpirt, W M, Basu, N, Morgan, M D, Poulton, C J, Draibe, J B, Krarup, E, Dospinescu, P, Dale, J A, Pendergraft, W F, Lee, K, Egfjord, M, Hogan, S L & Harper, L 2019, ' Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis : a multi-center retrospective cohort study ', BMC Nephrology, vol. 20, 58 . https://doi.org/10.1186/s12882-019-1226-0
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Chanouzas, D, McGregor, J A G, Nightingale, P, Salama, A D, Szpirt, W M, Basu, N, Morgan, M D, Poulton, C J, Draibe, J B, Krarup, E, Dospinescu, P, Dale, J A, Pendergraft, W F, Lee, K, Egfjord, M, Hogan, S L & Harper, L 2019, ' Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis : a multi-center retrospective cohort study ', BMC Nephrology, vol. 20, 58 . https://doi.org/10.1186/s12882-019-1226-0
BMC Nephrology, Vol 20, Iss 1, Pp 1-8 (2019)
Background Intravenous pulse methylprednisolone (MP) is commonly included in the management of severe ANCA associated vasculitis (AAV) despite limited evidence of benefit. We aimed to evaluate outcomes in patients who had, or had not received MP, alo
Autor:
Andrew McClean, Lorraine Harper, Neil Basu, David A. Jones, Matthew D. Morgan, Jos A. Bosch, Peter Nightingale
Publikováno v:
Arthritis Care & Research. 68:1332-1339
Objective: This study investigated differences in cardiorespiratory fitness, muscular function, perceived exertion, and anxiety/depression between patients and healthy controls (HCs) and assessed which of these variables may account for the fatigue e
Autor:
David Jayne, Pieter van Paassen, Kerstin Westman, Matthew D. Morgan, Michael Walsh, Caroline O. S. Savage, Rachel B Jones, Shunsuke Furuta, Chen Au Peh, Vladimir Tesar, Jan Willem Cohen Tervaert, Raashid Luqmani, Thomas H. Hauser, Mårten Segelmark
Publikováno v:
Annals of the Rheumatic Diseases, 74(6), 1178-1182. BMJ Publishing Group
Annals of the Rheumatic Diseases, 74(6), 1178-1182. BMJ PUBLISHING GROUP
Annals of the Rheumatic Diseases, 74(6), 1178-1182. BMJ PUBLISHING GROUP
ObjectivesThe RITUXVAS trial reported similar remission induction rates and safety between rituximab and cyclophosphamide based regimens for antineutrophil cytoplasm antibody (ANCA)-associated vasculitis at 12 months; however, immunosuppression maint
Autor:
Nadezhda A, Wall, C Coral, Dominguez-Medina, Sian E, Faustini, Charlotte N, Cook, Andrew, McClean, Mark D, Jesky, Marisol, Perez-Toledo, Matthew D, Morgan, Alexandra G, Richter, Charles J, Ferro, Paul, Cockwell, Paul A, Moss, Ian R, Henderson, Lorraine, Harper, Adam F, Cunningham
Publikováno v:
PLoS ONE
Patients with chronic kidney disease (CKD) have an increased risk of infection and poorer responses to vaccination. This suggests that CKD patients have an impaired responsiveness to all antigens, even those first encountered before CKD onset. To exa